Primary Record
Metfol-B
- In stock
- 5,322 g
- Purity
- 99.2 %
- CAS
- 5623-18-7
Compound Identifiers & Properties
- CAS
- 5623-18-7
- PubChem CID
- 135441780
- SMILES
- CN(CC1=CN=C2C(=N1)C(=O)NC(=N2)N)C3=CC=C(C=C3)C(=O)O
- Canonical SMILES
- CN(Cc1cnc2nc(N)[nH]c(=O)c2n1)c1ccc(C(=O)O)cc1
Names & Synonyms
- Metfol-B
- N10-Methyl Pteroic Acid
- N10-Methylpteroic acid
- 6-Deoxyglucitol
- N(10)-Methylpteroic acid
- 5623-18-7
- Pteroic acid, N10-methyl-
- n(10)-Methyl pteroic acid
- UNII-9RHB9JD89E
- Methotrexate EP Impurity D
- 10-methylpteroic acid
- 9RHB9JD89E
- Methotrexate Impurity D
- RefChem:201644
- NSC 408937
- AC1L2J6V
- Methotrexate impurity D CRS
- BRN 0338741
- DTXSID30204791
- CHEMBL475533
- SCHEMBL5006238
- SCHEMBL5006245
- NSC-408937
- SCHEMBL13529957
- SCHEMBL30097253
- DTXCID60127282
- C15H14N6O3
- CID21834
- ZINC1600996
- 2,4-diamino-N10-methylpteroic acid
- NSC408937
- C15-H14-N6-O3
- METHOTREXATE IMPURITY D [EP IMPURITY]
- 4-26-00-03948 (Beilstein Handbook Reference)
- J54.520A
- LS-35876
- 4-(((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)(methyl)amino)benzoic acid
- FT-0672159
- METHOTREXATE IMPURITY D (EP IMPURITY)
- p-((N-(2-Amino-4-hydroxy)pteridin-6-ylmethyl)-N-methylamino)benzoic acid
- 4-[(2-amino-4-oxo-1H-pteridin-6-yl)methyl-methylamino]benzoic acid
- A899775
- WLN: T66 BN DN GN JNJ CZ EQ H1N1&R BVQ
- 4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid
- Benzoic acid, p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)methylamino)-
- Q27272972
- B1370-184185
- Benzoic acid, 4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)methylamino)-
- BENZOIC ACID, p-((N-(2-AMINO-4-HYDROXY)PTERIDIN-6-YLMETHYL)-N-METHYLAMINO)-
- 4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoic Acid
- Benzoic acid, p-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]methylamino]-
- Benzoic acid,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]-
- 4-(((2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL)METHYLAMINO)BENZOIC ACID
- 4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-methylamino]benzoic acid
- 4-[Methyl(2-amino-4-hydroxypteridine-6-ylmethyl)amino]benzoic acid
- 4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzoic acid
- BENZOIC ACID, 4-(((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)METHYLAMINO)-
- p-[(2-Amino-4-hydroxy-6-pteridinyl)methyl(methyl)amino]benzoic acid
- p-[[(2-Amino-4-hydroxy-6-pteridinyl)methyl]methylamino]benzoic Acid
- 4-(((2-amino-4-hydroxypteridin-6-yl)methyl)(methyl)amino)benzoic acid
- 4-[[(2-amino-4-hydroxypteridin-6-yl)methyl] methylamino]benzoic acid
- 4-{[(2-AMINO-4-HYDROXYPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOIC ACID
- Benzoic acid, 4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)methylamino)-(9CI)
- Benzoic acid, 4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]-
- Benzoic acid, p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)methylamino)-(8CI)
- Benzoic acid, p-[[N-(2-amino-4-hydroxy)pteridin-6-ylmethyl]-N-methylamino]-
- 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic acid; N(10)-methylpteroic acid; Benzoic acid, 4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]-; Benzoic acid, 4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]- (9CI); Benzoic acid, p-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]methylamino]- (8CI); Metfol-B; NSC 408937; Pteroic acid, N10-methyl-; Methotrexate Imp. D (EP)